Actual Medicinal Product (AMP) Tivicay 50mg tablets (ViiV Healthcare UK Ltd)

Stability Information

(Some stability information inherited from generic)

Stability: Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes: No special precautions for storage.
Provenance: This compatibility recommendation is derived from Tivicay 50mg tablets (ViiV Healthcare UK Ltd).
Generic: Dolutegravir
Formulation: Dolutegravir 50mg tablets

Dolutegravir
- Dolutegravir 50mg tablets
  - Tivicay 50mg tablets (ViiV Healthcare UK Ltd)